Question-and-Answer Session
Operator
Thank you, sir. Ladies and gentlemen we will now begin the question-and-answer session. (Operator instructions). Our first question comes from the line of Ross Taylor with C.L. King, please go ahead.
Ross Taylor – C.L. King & Associates, Inc.
Hi. I got a couple of questions. First, I wondered if within you mean the royalty revenues or your diagnostic revenues, I mean how much you can give any information about how much you are getting from the Abbott royalties that expired in December?
Bruce Barclay
We’re not breaking that number out. As we said the number was down year-over-year and so it definitely had an impact on the results, but it’s not our intent to break those out.
Ross Taylor – C.L. King & Associates, Inc.
Okay. And I mean is there any chance, can you say anything about - how it was sequentially versus the September quarter?
Bruce Barclay
Sequentially it was up.
Ross Taylor – C.L. King & Associates, Inc.
Okay. And, another question would be, you said you still thought it was a reasonable chance to get your rough earnings guidance for the year-end. What would have to change versus the current quarter to make it more likely you could actually achieve that guidance because it looks like both your revenues would have to improve pretty materially from this quarter to get to that guidance?
Bruce Barclay
We see several positive indicators for the rest of the year and Phil touched on them I think nicely in his prepared remarks. We see potential growth in our Brookwood business on the organic basis and also with the PR Pharma technology that we acquired. In the quarter we had a very small amount of customer projects that were transferred over from PR Pharma, hitting the top line in Q1, and we expect that to hit in mass in Q2 and beyond. We also have a number of activities going on within the ophthalmology space and in particular we signed one of the largest R&D agreements in our recent history in ophthalmology in the last quarter, even though, the license has not yet been signed by that particular customer. So we have a number of customers still working in that space and paying us to do the work and we are very much – very optimistic about that going forward.
Ross Taylor – C.L. King & Associates, Inc.
Okay, all right. That’s helps. Thanks very much.
- To read the full transcript on Seeking Alpha, click here »
